Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: ballydog1 who wrote (13662)	5/25/2000 9:34:00 AM
From: aknahow	Respond to of 17367

NO! NO! """"""And you're also implying that the fear of antibiotic treatment for gastrointestinal disorders is holding back FDA approval/acceptance of a BLA for BPI ? """"" Hust the opposite. If antibiotics are a problem BPI might be a solution, either alone, or by permitting use of reduced dose of antibiotics.

To: ballydog1 who wrote (13662)	5/25/2000 10:30:00 AM
From: Bluegreen	Respond to of 17367

You stated>>>>>>>>>.And you're also implying that the fear of antibiotic treatment for gastrointestinal disorders is holding back FDA approval/acceptance of a BLA for BPI ?<<<<<<<YIKES!!!!!!!!! I wasn't implying that!!!!! NO WAY WAS I IMPLYING THAT!!!!!!!! I have no idea how you came to that conclusion!!!!!!!!!!!! BTW, I was talking about stocks in general not risky Biotechs exclusively. One thing to keep in mind though whether it is a risky biotech down 50 per cent or stalwart stock down 50 per cent YOU HAVE STILL LOST HALF YOUR MONEY!! It is then YOUR decision to keep investing at intervals or cut bait and run!!!!!!!!